Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Symptoms and General Pathology

Digestive System Diseases

Skin and Connective Tissue Diseases

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Rare Diseases

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Neoplasm Metastasis

Stomach Neoplasms

Breast Neoplasms

Triple Negative Breast Neoplasms

Esophageal Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Renal Cell

Small Cell Lung Carcinoma

Head and Neck Neoplasms

Kidney Neoplasms

Stomach Cancer

Esophageal Cancer

Renal Cell Carcinoma

Small Cell Lung Cancer

Herbal and Botanical

All Drugs and Chemicals

Cola

Investigating VIP236 in a dose escalation cohort in subjects with advanced solid tumor cancer

VIP236 will be administered by IV infusion once every 3 weeks.

VIP236

Vincerx Clinical Trials Contact

Research Site

Vincerx Study Director

Determine the safety, tolerability, and maximum tolerated dose (MTD) of IV administered VIP236 as monotherapy in patients with advanced solid tumor cancer

All comers solid tumor subjects with histologically confirmed advanced or metastatic disease who have relapsed or refractory to standard of care. Subjects must have exhausted all available standard therapies or be deemed ineligible for potential available therapies.

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

An Open-label, Multicenter Phase 1 Study to Characterize Safety, Tolerability, Preliminary Antitumor Activity and Pharmacokinetics of VIP236 Monotherapy in Subjects With Advanced Cancer

Vincerx Pharma, Inc.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer	NCT05712889	Neoplasms	VIP236	18 Years -	Vincerx Pharma, Inc.
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer	NCT05712889	Neoplasms	VIP236	18 Years -	Vincerx Pharma, Inc.

Spots Global Cancer Trial Database for vip236

Every month we try and update this database with for vip236 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for vip236

Every month we try and update this database with for vip236 cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for vip236 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.